Research output per year
Research output per year
Personal profile
Expertises
Gastroenterology; Short Bowel Syndrome; Intestinal failure; Intestinal Insufficiency
Main research areas
Glucagon-llike peptide-2 (GLP-2); Glucagon-like peptide-1 (GLP-1); Short Bowel Syndrome; Intestinal failure; Intestinal Insufficiency
Current research
A phase 2 trial testing ZP1848 in patients with SBS
"Potential conflicts of interest
None.
Fingerprint
Dive into the research topics where Rahim Mohammad Naimi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
The costs of home monitoring by telemedicine versus standard care for inflammatory bowel diseases - a Danish register-based, five-year follow-up study
Al-Sheikh, M., Ankersen, D. V., Olsen, J., Spanggaard, M., Peters-Lehm, C., Naimi, R. M., Bennedsen, M., Burisch, J. & Munkholm, P., 7 Aug 2024, (E-pub ahead of print) In: Journal of Crohn's & colitis.Research output: Contribution to journal › Journal article › Research › peer-review
-
Effects of glepaglutide, a long-acting glucagon-like peptide-2 analog, on intestinal morphology and perfusion in patients with short bowel syndrome: Findings from a randomized phase 2 trial
Naimi, R. M., Hvistendahl, M. K., Poulsen, S. S., Kissow, H., Pedersen, J., Nerup, N. A., Ambrus, R., Achiam, M. P., Svendsen, L. B. & Jeppesen, P. B., Jan 2023, In: Journal of Parenteral and Enteral Nutrition. 47, 1, p. 140-150 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
10 Citations (Scopus) -
Bile acid - farnesoid X receptor - fibroblast growth factor 19 axis in patients with short bowel syndrome: the randomized glepaglutide phase 2 trial
Hvistendahl, M. K., Naimi, R. M., Hansen, S. H., Rehfeld, J. F., Kissow, H., Pedersen, J., Dragsted, L. O., Sonne, D. P., Knop, F. K. & Jeppesen, P. B., May 2022, In: Journal of Parenteral and Enteral Nutrition. 46, 4, p. 923-935 13 p.Research output: Contribution to journal › Journal article › Research › peer-review
9 Citations (Scopus) -
Sitagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with short bowel syndrome and colon in continuity: an open-label pilot study
Naimi, R. M., Hvistendahl, M. K., Thomassen, L. M., Johnsen, H., Christiansen, C. B., Holst, J. J., Hartmann, B. & Jeppesen, P. B., May 2021, In: BMJ Open Gastroenterology. 8, 1, p. e000604 e000604.Research output: Contribution to journal › Journal article › Research › peer-review
-
Effect of Glepaglutide, a Long-Acting Glucagon-Like Peptide-2 Analog, on Gastrointestinal Transit Time and Motility in Patients With Short Bowel Syndrome: Findings From a Randomized Trial
Hvistendahl, M. K., Naimi, R. M., Enevoldsen, L. H., Madsen, J. L., Fuglsang, S. & Jeppesen, P. B., Nov 2020, In: Journal of Parenteral and Enteral Nutrition. 44, 8, p. 1535-1544 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
28 Citations (Scopus)